Cite
Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model
MLA
Naoya Uchida, et al. “Fertility-Preserving Myeloablative Conditioning Using Single-Dose CD117 Antibody-Drug Conjugate in a Rhesus Gene Therapy Model.” Nature Communications, vol. 14, no. 1, Oct. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41467-023-41153-5.
APA
Naoya Uchida, Ulana Stasula, Selami Demirci, Paula Germino-Watnick, Malikiya Hinds, Anh Le, Rebecca Chu, Alexander Berg, Xiong Liu, Ling Su, Xiaolin Wu, Allen E. Krouse, N. Seth Linde, Aylin Bonifacino, So Gun Hong, Cynthia E. Dunbar, Leanne Lanieri, Anjali Bhat, Rahul Palchaudhuri, … John F. Tisdale. (2023). Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model. Nature Communications, 14(1), 1–11. https://doi.org/10.1038/s41467-023-41153-5
Chicago
Naoya Uchida, Ulana Stasula, Selami Demirci, Paula Germino-Watnick, Malikiya Hinds, Anh Le, Rebecca Chu, et al. 2023. “Fertility-Preserving Myeloablative Conditioning Using Single-Dose CD117 Antibody-Drug Conjugate in a Rhesus Gene Therapy Model.” Nature Communications 14 (1): 1–11. doi:10.1038/s41467-023-41153-5.